Long-Term Safety and Efficacy of Two Different Antimuscarinics, Imidafenacin and Solifenacin, for Treatment of Overactive Bladder: A Prospective Randomized Controlled Study

By  

Urologia Internationalis, Vol. 90, Iss. 2, 2012-11 ,pp. : 161-167

Karger

Access to resources Recommend Favorite

A randomized, double‐blind, placebo‐controlled trial to evaluate the efficacy, safety, and tolerability of long‐term treatment with prucalopride

By  

NEUROGASTROENTEROLOGY & MOTILITY (ELECTRONIC), Vol. 27, Iss. 6, 2015-06 ,pp. : 805-815

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy of fesoterodine over 24 hours in subjects with overactive bladder

By Staskin David   Michel Martin C.   Nitti Victor   Morrow Jon D.   Wang Joseph   Guan Zhonghong  

Current Medical Research and Opinion, Vol. 26, Iss. 4, 2010-04 ,pp. : 813-818

Informa Healthcare

Access to resources Recommend Favorite

Pharmacological treatment for overactive bladder in women

By Robinson Dudley   Cardozo Linda  

Women's Health, Vol. 2, Iss. 2, 2006-03 ,pp. : 239-250

Future Medicine

Access to resources Recommend Favorite

Effect of fesoterodine 4 mg on bladder diary and patient-reported outcomes during the first week of treatment in subjects with overactive bladder

By Corcos Jacques   Angulo Javier C.   Garely Alan D.   Carlsson Martin   Gong Jason   Guan Zhonghong  

Current Medical Research and Opinion, Vol. 27, Iss. 5, 2011-05 ,pp. : 1059-1065

Informa Healthcare

Access to resources Recommend Favorite